← Back to Clinical Trials
Recruiting NCT06538402

NCT06538402 Ten Versus Fifteen Centimeter Pouch in IPAA Surgery

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT06538402
Status Recruiting
Phase
Sponsor Odense University Hospital
Condition Ulcerative Colitis
Study Type INTERVENTIONAL
Enrollment 120 participants
Start Date 2025-07-03
Primary Completion 2028-07-03

Eligibility & Interventions

Sex All sexes
Min Age 18 Years
Max Age 60 Years
Study Type INTERVENTIONAL
Interventions
10 cm pouch15 cm pouch

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.

This trial targets 120 participants in total. It began in 2025-07-03 with a primary completion date of 2028-07-03.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

The aim of this randomized controlled trial is to compare outcome after construction of an ileal (J-shaped) reservoir of 10 versus 15 centimeters in primary ileal pouch-anal anastomosis surgery.

Eligibility Criteria

Inclusion Criteria: * Undergoing ileal pouch-anal anastomosis (IPAA) for ulcerative colitis or familial adenomatous polyposis (FAP) (implying a normal sphincter function as judged by history and clinical examination) * Signed informed consent * Able to perform both a small (10 cm) and medium-size (15 cm) pouch with adequate reach and no tension as determined subjectively by the surgeon intraoperatively

Contact & Investigator

Central Contact

Anders Mark-Christensen, MD, PhD

✉ anders.mark.christensen2@rsyd.dk

📞 +45 51236691

Frequently Asked Questions

Who can join the NCT06538402 clinical trial?

This trial is open to participants of all sexes, aged 18 Years or older, up to 60 Years, studying Ulcerative Colitis. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT06538402 currently recruiting?

Yes, NCT06538402 is actively recruiting participants. Contact the research team at anders.mark.christensen2@rsyd.dk for enrollment information.

Where is the NCT06538402 trial being conducted?

This trial is being conducted at Aarhus, Denmark, Hvidovre, Denmark.

Who is sponsoring the NCT06538402 clinical trial?

NCT06538402 is sponsored by Odense University Hospital. The trial plans to enroll 120 participants.

Related Trials

Related Intelligence Guides

In-depth guides covering this condition's trials, eligibility, and what to expect.

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: September 2026  ·  Data Methodology